Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 TrialYuqin Song, Xin Du, Wei Liu et al.|Advances in Therapy|2021Cited by 19
Influence of the examination position and distension medium on the rectal sensory test in patients with functional constipationChang-Fang Xiao, Yifan Li, Yangyang Sun et al.|BMC Gastroenterology|2024Cited by 2